Key Meeting + Program Updates
All PDAB meetings will now begin at 8:00 AM (starting Aug 20)
One board member shared a conflict due to owning pharmacies
Ralph Magrish left his role as Executive Director. The search is on for a new leader: deadline to apply is July 28
Applications for a new PDAB member have closed and are under review
Affordability Review Discussion
Migraine meds: Ajovy, Emgality, Nurtec, Ubrelvy
Differences in how they work and how they’re given
Prior approvals are often required (which can delay treatment)
Affordability Review Discussion Continued
Vraylar: Used a lot by Medicaid patients for schizophrenia
Entresto: A heart failure drug
with no alternative
Worries about higher prices hurting people of color
Some say it’s already affordable with help programs
Looking Ahead
Next PDAB Meeting: August 20, 2025 @ 8 AM
Focus on migraine drugs first
Board packets will be clearer, with key info up front
Board wants better ways to define “affordability”
In this week's meeting, the #Oregon Prescription Drug Affordability Board (#PDAB) focused on program changes their first drug #AffordabilityReviews. Learn more in the slides →
Next meeting: August 20, 2025 @ 8 AM.
#HealthPolicySky #Migraines #Ajovy #Emgality #Nurtec #Ubrelvy #Vraylar #Entresto #OCAP